Evidence map›Paper›PMID 27273195›Full record

ArticleScientific reports2016

CRF receptor 1 antagonism and brain distribution of active components contribute to the ameliorative effect of rikkunshito on stress-induced anorexia.

Sachiko Mogami, Chiharu Sadakane, Miwa Nahata, Yasuharu Mizuhara, Chihiro Yamada, Tomohisa Hattori, Hiroshi Takeda

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
4.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Recent Advances inMetabolites · 2022
    Review
  5. Review
  6. Article
  7. Review
  8. Usefulness of a Kampo Medicine on Stress-Induced Delayed Gastric Emptying in Mice.Evidence-based complementary and alternative medicine : eCAM · 2020
    Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Sachiko MogamiTsumura Research Laboratories, Tsumura &Co., Ibaraki 300-1192, Japan.
Chiharu SadakaneTsumura Research Laboratories, Tsumura &Co., Ibaraki 300-1192, Japan.
Miwa NahataTsumura Research Laboratories, Tsumura &Co., Ibaraki 300-1192, Japan.
Yasuharu MizuharaTsumura Research Laboratories, Tsumura &Co., Ibaraki 300-1192, Japan.
Chihiro YamadaTsumura Research Laboratories, Tsumura &Co., Ibaraki 300-1192, Japan.
Tomohisa HattoriTsumura Research Laboratories, Tsumura &Co., Ibaraki 300-1192, Japan.
Hiroshi TakedaPathophysiology and Therapeutics, Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo, Hokkaido 060-0812, Japan.
Tsumura Research Institute (Japan) · JPHokkaido University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rikkunshito (RKT), a Kampo medicine, has been reported to show an ameliorative effect on sustained hypophagia after novelty stress exposure in aged mice through serotonin 2C receptor (5-HT2CR) antagonism. We aimed to determine (1) whether the activation of anorexigenic neurons, corticotropin-releasing factor (CRF), and pro-opiomelanocortin (POMC) neurons, is involved in the initiation of hypophagia induced by novelty stress in aged mice; (2) whether the ameliorative effect of RKT is associated with CRF and POMC neurons and downstream signal transduction; and (3) the plasma and brain distribution of the active components of RKT. The administration of RKT or 5-HT2CR, CRF receptor 1 (CRFR1), and melanocortin-4 receptor antagonists significantly restored the decreased food intake observed in aged male C57BL/6 mice in the early stage after novelty stress exposure. Seven components of RKT exhibited antagonistic activity against CRFR1. Hesperetin and isoliquiritigenin, which showed antagonistic effects against both CRFR1 and 5-HT2CR, were distributed in the plasma and brain of male Sprague-Dawley rats after a single oral administration of RKT. In conclusion, the ameliorative effect of RKT in this model is assumed to be at least partly due to brain-distributed active components possessing 5-HT2CR and CRFR1 antagonistic activities.

Indexed as

AnimalsAnorexiaBrainCRF Receptor, Type 1Drugs, Chinese HerbalMaleMiceRatsRats, Sprague-DawleyReceptors, Corticotropin-Releasing HormoneStress, PsychologicalCRF Receptor, Type 1Drugs, Chinese Herballiu-jun-zi-tangReceptors, Corticotropin-Releasing Hormone

Identifiers

PMID27273195
PMCPMC4897628
OpenAlexW2418126959

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.